Delivery Order SPE2DB22D1106-SPE2DB24FFAB3
Award Date
7/2/24
Potential Completion Date
7/3/24
Potential Value
$2.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,979.78 firm fixed-price delivery order is for the supply of 4566579657 ! GLYCOPYRROLATE 0.2 MG/ML VIAL 2ML. The award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply the U.S. Department of Defense (DoD) and other government agencies with a specific medication, glycopyrrolate 0.2 mg/ml vial 20ml. The contract, valued at $2,704.75, is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the Defense Logistics Agency (DLA) Troop Support Medical, worth up to $999,999,999.00 through December 31, 2025. This...
This federal contract award, valued at $1,030.40, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The contract, which is not set-aside, is for the delivery of GLYCOPYRROLATE INJECT, a pharmaceutical product, with a completion date of August 27, 2024. Amerisourcebergen, one of the largest pharmaceutical distributors in the United States, has been awarded numerous federal contracts to supply a wide range of...
This federal contract award, SPE2DB20D7059|SPE2DB25FPWL4, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,495.04 fixed-price delivery order is for the supply of 4,566,696,580 units of the medication Glycopyrrolate 1 mg/5 ml vial. The contract has an ultimate completion date of December 13, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $3,130.32 firm fixed price delivery order is for the supply of the pharmaceutical product glycopyrrolate injection. The contract has an ultimate completion date of July 7, 2023. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,910.85 firm fixed-price contract is for the supply of GLYCOPYRROLATE 0.2 MG/ML medication, a critical pharmaceutical product used in medical treatment. The contract has an ultimate completion date of December 10, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award, valued at $1,598.28, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of GLYCOPYRROLATE INJECT, a pharmaceutical product. The contract has a September 10, 2024 ultimate completion date and uses a Firm Fixed Price pricing type. This award is not associated with a set-aside designation. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $3,442.46, is for the supply of GLYCOPYRROLATE INJECT, a medication, and is a firm fixed-price delivery order with an ultimate completion date of August 15, 2024. The contract has no set-aside designation. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal...
This federal contract award to AmerisourceBergen Drug Corp's Corporate Office Division is for the delivery of the medication glycopyrrolate 0.2 mg/ml in 20ml vials. The $1,661.09 firm-fixed-price delivery order was awarded on May 16, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical, with a completion date of May 17, 2024. AmerisourceBergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of 4567514733 GLYCOPYRROLATE 4 MG/20 ML VIAL 20ML and has a ceiling value of $1,708.45. The contract is a Firm Fixed Price Delivery Order without any set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract...